ProCE Banner Activity

InterACT Oncology Team Training: Improving Clinical Outcomes for Patients With High-Risk HR-Positive/HER2-Negative Early-Stage Breast Cancer

Slideset

Download this slideset from a workshop series on multidisciplinary care of patients with high-risk HR-positive/HER2-negative early-stage breast cancer, including patient selection for adjuvant CDK4/6 inhibitors, toxicity management, and adherence considerations.

Released: July 25, 2024

Expiration: July 24, 2025

Share

Faculty

Joyce O'Shaughnessy

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Chair, Breast Disease Committee
Sarah Cannon Research Institute
Texas Oncology
Dallas, Texas

Sara M. Tolaney

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Associate Director, Susan F. Smith Center for Women’s Cancers
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC. in partnership with Smart Patients

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Smart Patients

ProCE Banner